Previous 10 | Next 10 |
The following slide deck was published by Vapotherm, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Vapotherm, Inc. 2022 Q4 - Results - Earnings Call Presentation
Vapotherm press release ( NYSE: VAPO ): Q4 GAAP EPS of -$0.78 in-line. Revenue of $18.7M (-15.8% Y/Y) beats by $0.84M . Fiscal Year 2022 Summary Total revenue for 2022 was $66.8 million Adjusted EBITDA was negative $12.0 million for the fourth quarter of ...
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced fourth quarter and fiscal year 2022 financial results. Fourth Quarter 2022 Summary Total revenue for the fourth quarter of 2022 was $18.7 million Gross margin was 27.5% in t...
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...
Global medical technology company, Vapotherm ( NYSE: VAPO ) has entered into a securities purchase agreement with investors through a private placement financing for gross proceeds of ~$23M. Pursuant to the agreement, the company agreed to issue 17.5M shares and pre-funded warrant...
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...
Summary Vapotherm has been struggling for years. The pandemic which appeared to be a blessing has not benefited the business at all; in fact, the contrary. The fundamental picture is too dire to become upbeat, even at these low levels. Shares remain unattractive in my book despi...
SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors follow...
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sal...
NEW YORK, NY / ACCESSWIRE / June 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE: SQSP)'s ...
Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private PR Newswire EXETER, N.H. , June 17, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has signed a defin...